|1.||Weight Loss (Weight Reduction)
|4.||Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)
|5.||Hypertension (High Blood Pressure)
|1.||Wall, Michael: 5 articles (10/2015 - 05/2005)|
|2.||Friedman, Deborah I: 5 articles (08/2014 - 01/2005)|
|3.||Miller, Neil R: 5 articles (06/2013 - 05/2002)|
|4.||Falardeau, Julie: 4 articles (09/2015 - 05/2005)|
|5.||Rigamonti, Daniele: 4 articles (06/2013 - 10/2004)|
|6.||Kesler, A: 4 articles (12/2004 - 03/2000)|
|7.||Kupersmith, Mark J: 3 articles (10/2015 - 04/2014)|
|8.||McDermott, Michael P: 3 articles (10/2015 - 04/2014)|
|9.||Bruce, Beau B: 3 articles (09/2015 - 08/2011)|
|10.||Regen, Francesca: 3 articles (06/2015 - 02/2014)|
|1.||Acetazolamide (Diamox)FDA LinkGeneric
02/01/2011 - "In the future, results from the ongoing multicenter, double-blind, placebo-controlled Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) will provide important data regarding the efficacy of acetazolamide and the utility of diet and exercise."
05/01/1999 - "We report a study of 5 patients with benign intracranial hypertension, and severe visual loss (visual field loss and visual acuity reduced to 1/10 or less) not improved by medical therapy (acetazolamide). "
06/01/1997 - "The objective of the study was to determine the efficacy of optic nerve sheath fenestration (ONSF) in eyes with progressive visual or field loss in pseudotumor cerebri in spite of medical therapy with oral Diamox. "
01/01/2016 - "Investigators of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT) reported beneficial effects of acetazolamide in patients with mild visual loss. "
04/23/2014 - "Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial."
|2.||Factor IX (PTC)FDA LinkGeneric
05/01/2015 - "To investigate the frequency of visual loss (VL), possible predictive factors of VL, and improvement in patients with pseudotumor cerebri (PTC) syndrome. "
06/01/1996 - "We conducted a retrospective study of 27 patients with pseudotumor cerebri (PTC) treated with at least one lumboperitoneal shunt (LPS) to ascertain the efficacy of this treatment. "
06/01/1993 - "We reviewed the efficacy of CSF diversion for pseudotumor cerebri (PTC) in patients from six different institutions. "
05/01/2011 - "Pseudotumor cerebri (PTC) is a syndrome characterized with increased intracranial pressure, normal cerebrospinal fluid content (CSF), and a normal brain on imaging studies. "
01/01/2007 - "The diagnosis of pseudotumor cerebri (PTC) was confirmed by an increased intracranial pressure and normal neuroimaging studies of the brain, including magnetic resonance (MR) venography. "
|3.||Furosemide (Lasix)FDA LinkGeneric
04/01/1994 - "The purpose of this study was to investigate the efficacy of combined therapy with acetazolamide and furosemide in normalizing intracranial pressure in children with pseudotumor cerebri. "
02/01/2011 - "Here, we describe a case of a 13-year-old girl with idiopathic intracranial hypertension refractory to long-term trials of acetazolamide and furosemide at maximally tolerated doses. "
04/01/1994 - "Combined therapy with acetazolamide and furosemide is an effective first-line method of treating raised intracranial pressure in children with pseudotumor cerebri. "
04/01/1994 - "Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series."
04/01/1979 - "A group of 6 women diagnosed as suffering from pseudotumor cerebri had measurement of their plasma renin activity and aldosterone levels at baseline, following plasma volume contraction by furosemide and after dexamethasone therapy. "
|4.||topiramate (Topamax)FDA LinkGeneric
05/01/2015 - "Besides a similar clinical presentation, idiopathic intracranial hypertension (IIH) and chronic migraine (CM) also share relevant risk factors, show a higher prevalence of allodynic symptoms and both respond to topiramate. "
11/01/2006 - "Topiramate resolves headache from pseudotumor cerebri."
05/01/2004 - "Topiramate-responsive headache due to idiopathic intracranial hypertension in Behçet syndrome."
06/01/2008 - "Closed-angle glaucoma after topiramate therapy for migraine in a patient with undiagnosed pseudotumor cerebri."
01/01/2006 - "Topiramate, pseudotumor cerebri, weight-loss and glaucoma: an ophthalmologic perspective."
|5.||Growth Hormone (Somatotropin)IBA
01/01/2006 - "Delayed onset of pseudotumor cerebri syndrome 7 years after starting human recombinant growth hormone treatment."
04/01/2010 - "We experienced a case of a Japanese boy who developed intractable idiopathic intracranial hypertension (IIH) during growth hormone (GH) treatment. "
05/01/2002 - "Growth hormone treatment and pseudotumor cerebri: coincidence or close relationship?"
05/01/1998 - "There was no increase in the recurrence rate of the underlying disease and no adverse event could be directly attributed to growth hormone treatment, apart from one case of benign intracranial hypertension that resolved on stopping treatment with growth hormone. "
04/01/1998 - "Benign intracranial hypertension and recombinant growth hormone therapy in Australia and New Zealand."
12/01/2012 - "Acquired bilateral myelinated retinal nerve fibers after unilateral optic nerve sheath fenestration in a child with idiopathic intracranial hypertension."
12/01/2007 - "To evaluate optical coherence tomography (OCT) measurement of peripapillary retinal nerve fiber layer (RNFL) and macular thickness in children with pseudotumor cerebri. "
06/01/2006 - "Retinal nerve fiber layer analysis in idiopathic intracranial hypertension."
06/01/2004 - "To our knowledge, no reports have described in detail retinal damage resulting from pseudotumor cerebri. "
08/01/1995 - "Changes in the retinal nerve fiber layer observed in patients with idiopathic intracranial hypertension provide objective information regarding the status of their optic nerve and may improve their clinical management."
05/01/1988 - "[A case of pseudotumor cerebri probably due to the withdrawal of adrenal corticosteroid hormone]."
01/01/1983 - "Contrary to previous reports, this patient's clinical course suggests that thyroid hormone deficiency and pseudotumor cerebri are not causally related."
07/17/1982 - "Hormone replacement treatment and benign intracranial hypertension."
06/05/1982 - "Hormone replacement treatment and benign intracranial hypertension."
01/01/1984 - "In neurology, some epidemiological and clinical data suggest the implication of steroid hormones and receptors in human CNS: 1) the influence of oestrogens in tardive dyskinesia; 2) the relevance of hormonal changes in benign intracranial hypertension; 3) the usefulness of glucocorticoid therapy in many patients with intracranial tumors and/or edema. "
03/01/2009 - "Steroids have been linked to predisposition to hypercoagulable states, but there are no reports identified by these authors that link performance-enhancing steroids with pseudotumor cerebri as a result of a coagulation dyscrasia."
01/01/1985 - "At present, when a considerable number of children are on long-term steroids for various reasons, pseudotumor cerebri should be considered in the list of complications during abrupt steroid withdrawal."
09/01/1963 - "PSEUDOTUMOR CEREBRI IN CHILDREN SECONDARY TO ADMINISTRATION OF ADRENAL STEROIDS."
03/01/2009 - "A 17-year-old male with pseudotumor cerebri secondary to performance-enhancing steroids triggering venous thrombosis in the brain."
08/01/1987 - "Weight loss is recommended in the treatment of benign intracranial hypertension (BIH) but is difficult to achieve because of the administration of steroids. "
11/01/1993 - "In this child, pseudotumor cerebri and associated hypovitaminosis improved after combined corticosteroid and vitamin treatment."
10/01/1996 - "[Pseudotumor cerebri caused by vitamin excess due to intake of milk enriched with A and D vitamins. "
05/01/2007 - "On measurement of fat-soluble vitamins, levels of vitamin A were approximately 10% of the lower normal range, in the absence of objective evidence of pseudotumor cerebri. "
01/01/1992 - "The only well-established human vitamin neurotoxic effects are those due to hypervitaminosis A (pseudotumor cerebri) and pyridoxine (sensory neuropathy). "
09/01/1995 - "In a previous retrospective study, 4 of 9 patients with benign intracranial hypertension were unexpectedly positive for intrathecal synthesis of immunoglobulin (Ig) G by quantitative measurement (log IgG index). "
05/01/1990 - "Three patients with pediatric systemic lupus erythematosus (PSLE) and autoimmune thrombocytopenia (AT), who developed unacceptable side effects (pseudotumor cerebri, hypertension, excessive weight gain) from treatment with steroids, were treated successfully with vincristine (2 patients) or intravenous immunoglobulin (1 patient). "
01/01/1981 - "We conclude that optic nerve decompression is effective in the treatment of benign intracranial hypertension, has its effect locally, and in some patients may lower the intracranial pressure."
10/01/2000 - "In patients with pseudotumor cerebri with progressive visual loss despite maximum medical therapy, optic nerve sheath decompression is a safe and effective means of stabilizing visual acuity and the visual fields of those tested."
10/01/2000 - "After optic nerve sheath decompression for pseudotumor cerebri, visual acuity stabilized or improved in 148 of 158 (94%) eyes, and visual fields stabilized or improved in 71 of 81 (88%) eyes. "
12/01/1995 - "Up to 35% of patients undergoing optic nerve sheath decompression (ONSD) for pseudotumor cerebri who show initial improvement in visual function later show deterioration in visual field and acuity. "
01/01/2015 - "In this study, we aimed to present the outcome of endoscopic endonasal optic nerve decompression and to review the literature on this treatment modality in 2 patients diagnosed with pseudotumor cerebri that was unresponsive to medical therapy and associated with progressive visual loss. "
12/01/2010 - "The use of the Strata NSC valve and small lumen peritoneal catheter is effective in treating pseudotumor cerebri and is beneficial in terms of markedly reducing overdrainage complications compared with other reported series of cases in which an LP shunt has been placed. "
04/01/2005 - "Catheter studies show that patients with benign intracranial hypertension (BIH) frequently have high pressures in the intracranial venous sinuses proximal to stenotic lesions in the transverse sinuses. "
07/01/2014 - "Cervical puncture and perimedullary cistern shunt placement for idiopathic intracranial hypertension: An alternative to lumbar cistern or cerebral ventricular catheter placement a report of two cases."
01/01/2013 - "A 47-year-old female with pseudotumor cerebri admitted after the peritoneal catheter protruded from her mouth during retching. "
01/01/2010 - "A 26-year-old primiparous patient with intractable benign intracranial hypertension treated by cerebrospinal fluid drainage through an indwelling spinal catheter was expecting twins. "
04/13/2004 - "The authors investigated 17 patients with idiopathic intracranial hypertension (IIH), correlating laser scanning tomography of the optic nerve with CSF opening pressure. "
04/13/2004 - "Laser scanning tomography of the optic nerve vs CSF opening pressure in idiopathic intracranial hypertension."
11/01/1998 - "To determine the sensitivity of confocal scanning laser ophthalmoscopy (SLO) in detecting clinically significant changes in papilloedema secondary to idiopathic intracranial hypertension (IIH) and the correlation with visual field loss. "
11/01/1998 - "Use of scanning laser ophthalmoscopy to monitor papilloedema in idiopathic intracranial hypertension."
11/25/1995 - "Scanning laser tomography in benign intracranial hypertension."
01/01/1991 - "Evaluation of the efficacy of optic nerve sheath fenestration in pseudotumor cerebri has been hindered by a lack of quantitative indicators of visual function before and after treatment. "
12/01/2012 - "To report the unusual development of bilateral myelinated retinal nerve fibers (MRNF) adjacent to the optic nerve in a child after treatment of idiopathic intracranial hypertension (IIH) with unilateral optic nerve sheath fenestration (ONSF) and to discuss the etiology of acquired MRNF. "
08/01/1998 - "[Benign intracranial hypertension after treatment with pefloxacin]."
11/01/2004 - "In all but one case, the pseudotumor cerebri manifested 2 to 4 weeks after treatment of hypercortisolism or cessation of hydrocortisone replacement. "
02/01/2000 - "Pseudotumor cerebri after treatment of relapsed acute promyelocytic leukemia with arsenic trioxide."
11/01/2008 - "An 18-year-old man in remission from acute myelogenous leukemia 3 years after a bone marrow transplant presented with signs of pseudotumor cerebri, including headache, visual changes, and papilledema. "
09/01/1997 - "We describe two patients with renal transplants who developed pseudotumor cerebri (PTC) in the course of their follow-up. "
03/01/1993 - "Deteriorating renal function with acetazolamide in a renal transplant patient with pseudotumor cerebri."
01/01/2007 - "Pseudotumor cerebri after allogeneic bone marrow transplant associated with cyclosporine a use for graft-versus-host disease prophylaxis."
03/01/1993 - "Treatment with acetazolamide for pseudotumor cerebri (PTC) in a renal transplant patient led to an acute, but reversible deterioration in renal function. "